Look for:

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001
2021/12/07 17:35:25
Price
45.71 EUR
Difference 2.52% (1.13)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)43,801 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open45.00 EUR
High45.825 EUR
Low44.65 EUR
Close (prev. day)44.585 EUR
VWAP45.58923 EUR
Volume (pcs)4,101,114
Trading volume186,966,623.38
Number of trades17,092
Last size1,647,890

Futures and Options

Related Futures46
Related Options-

PDF Downloads

Annual report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/12/07 17:35:25
Price
45.71 EUR
Difference 2.52% (1.13)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)43,801 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open45.00 EUR
High45.825 EUR
Low44.65 EUR
Close (prev. day)44.585 EUR
VWAP45.58923 EUR
Volume (pcs)4,101,114
Trading volume186,966,623.38
Number of trades17,092
Last size1,647,890

Performance and Risk

6M1Y3Y
Perf (%)-14.88%-6.61%-29.32%
Perf (abs.)-7.84-3.17-18.59
Beta0.710.951.03
Volatility19.4624.5433.62
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)44.73 EUR (4,129,176)
Ø price 30 days | Ø volume 30 days (pcs.)48.40 EUR (2,883,061)
Ø price 100 days | Ø volume 100 days (pcs.)47.91 EUR (2,737,963)
Ø price 250 days | Ø volume 250 days (pcs.)50.69 EUR (3,027,887)
YTD High | date57.73 EUR (2021/05/14)
YTD Low | date43.91 EUR (2021/12/06)
52 Weeks High | date57.73 EUR (2021/05/14)
52 Weeks Low | date43.91 EUR (2021/12/06)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/12/0717:3545.71 EUR186.9717,092
Vienna Stock Exchange2021/12/0717:3245.665 EUR0.048
Tradegate2021/12/0718:0745.545 EUR13.811,723
Stuttgart2021/12/0718:1045.59 EUR1.34235
SIX Swiss Exchange2020/05/1417:3560.11 EUR0.001
SIX Swiss Exchange2020/03/0617:35104.00 CHF0.001
Munich2021/12/0718:0745.785 EUR0.029
London Stock Exchange European Trade Reporting2021/12/0717:3045.695 EUR4.587
Hanover2021/12/0716:0945.55 EUR0.066
Hamburg2021/12/0712:0245.565 EUR0.0511
Frankfurt2021/12/0717:3645.77 EUR0.6491
FINRA other OTC Issues2021/12/0717:5751.00 USD0.053
Duesseldorf2021/12/0718:0045.555 EUR0.0114
Budapest Stock Exchange2021/12/0717:2016,612.00 HUF0.236
Bucharest Stock Exchange2021/12/0714:52229.05 RON0.002
Borsa Italiana MTF Trading After Hours2021/12/0120:1445.10 EUR0.002
Borsa Italiana MTF Global Equity Market2021/12/0717:3545.73 EUR0.3986
Berlin2021/12/0718:0045.80 EUR0.0821

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: 49-214-30-1
Fax: -
E-mail: -

PDF Downloads

Annual report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

Werner BaumannChairman of Managing Board
Heiko SchipperMember of Executive Committee
Liam Condon (bis 31.12.2021)Member of Executive Committee
Rodrigo Santos (ab 31.12.2021)Member of Executive Committee
Sarena LinMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Fei-Fei LiMember of Supervisory Board
Norbert BischofbergerMember of Supervisory Board
Otmar WiestlerMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Simone Bagel-TrahMember of Supervisory Board
Thomas ElsnerMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Michael Schmidt-KiesslingMember of Supervisory Board
Oliver ZühlkeMember of Supervisory Board
Petra Reinbold-KnapeMember of Supervisory Board
Reiner HoffmannMember of Supervisory Board
Robert GundlachMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.